Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Jim Cramer Says Eli Lilly and Company (LLY)’s ‘Going To Win’

We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks.

In his second appearance on Squawk on the Street after the Fed’s interest rate cut, Jim Cramer had a lot to say about the Fed’s decision and the Personal Consumption Expenditure (PCE) data release. The PCE data was a boon for investors as it signaled that inflation was dropping. Cramer started by pointing out that the PCE data release was “somewhat reassuring. Because if we do get lower inflation, I think it’s certainly a possibility because we’re starting to get our arms around what’s really causing inflation. Then it doesn’t seem so devastating, what happened on Wednesday.” He added that the release doesn’t reverse the market fall since he thinks that the market fell after “rampant Bitcoin speculation, after speculation in nuclear power, after speculation in quantum computing, after speculation in what I regard as being these, really kind of, I’ll put them in commercial aerospace, because of Musk.” Cramer believes that the central bank officials ” don’t wanna see that. They don’t point blank say it. I wish they had. But that’s what’s going on here, it’s the air going out of that balloon.”

However, while he believes that the market might have fallen because of the balloon ‘deflating’, this has created an interesting opportunity. According to Cramer, the speculation in the market has been replaced by “some really interesting fundamental news. And I think that we are the most oversold that we’ve been in, you’re up there in terms of the ten-year low, if you bought, and I’ve got some numbers that are saying if you bought today, three months later, you made money. In every single case, it’s really rather extraordinary.”

While the threat of a US government shutdown over the holidays has been averted, Cramer also had some interesting takes on the conflict in Congress. He shared that “I studied shutdowns for my last book. And every shutdown was a buying opportunity. They’re always as frightening as the way we’ve been covering this morning. Uh, and they always end up being a buying opportunity. Because they are considered to be so frightening.”

Cramer backed his claims by sharing data that took all night to calculate. He added “What I’m saying, I know this is against the grain of what I’m hearing, but you’re supposed to buy today not sell it. All the data I have, all the data I have, I mean I’ve got data going back ten years. And. . . [THE] oscillator, the S&P oscillator that I follow. It’s minus eight, uh, thank you to the S&P people.”

The negative oscillator reading means that buying stocks at the dip and then holding them for certain time periods has historically yielded returns. Cramer pointed out “You have a median gain three months later of 4.55, sixty days, 11.0. I mean, this is unassailable stuff. I couldn’t believe it. I asked them to calculate it. Took them all night to calculate. But oh my! You buy today, you make money! I don’t know what to say, the data is the data! The forecast is the forecast! The guidance is the guidance!” He continued and added that while watching the markets early morning on Friday, he wondered “Who are these numbskulls who’re doing this. They are people who are sleep-deprived, they don’t know what they’re doing. And frankly, we now know we have become the crack house. We are the crack house!”

Cramer didn’t hold back when criticizing investors who are obsessed with zero-day options. These options expire after the trading day ends, and therefore, they are for those investors who seek to profit from the market’s daily moves. According to Cramer, people who trade these options “are debilitated. They are, they believe the long term means you gotta hold it to the afternoon. Uh, these people I feel bad for them because they’re losing fortunes, they don’t know what they’re doing.”

He believes that day trading is more “addictive” than online gambling. “Depression, anxiety, all the things that are tell-tale of how to wreck your life are now part of our market,” believes Cramer. In fact, according to him, options trading needs to be talked about more. Cramer pointed out that “$538 million is options! Out of $1.9 billion. $538 million! Crypto is $268 million! Their next big line is margin interest! $220 mil! Why aren’t people talking about this?”

According to Cramer, “These people are losing a lot of money. And maybe they ought to take a little more long-term approach. We have to say, look, if you think that you can trade up against professionals, and the professionals have software, the professionals have algorithms, the professionals know more than the people who are day trading. That’s what I’m saying.” However, he does believe that “you can balance it. You can do some of this stuff for fun if you want to. But my father was wiped out by trading the National Video. Now go Google National Video. He did day trading for it all the way down.”

Our Methodology

To make our list of the stocks that Jim Cramer talked about, we listed down all the stocks he mentioned during CNBC’s Squawk on the Street aired on Friday.

For these stocks, we also mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds invest in? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).

An array of pharmaceutical pills with the company’s logo on the bottle.

Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders In Q3 2024: 106

Eli Lilly and Company (NYSE:LLY) is one of the hottest stocks in the pharmaceutical industry because of its strong position in the weight loss drug market. Its shares have gained 183% since the start of 2022. Along with weight loss drugs, Eli Lilly and Company (NYSE:LLY) also targets other lucrative disease markets such as cancer. These provide it with a portfolio of pricey treatments that help drive revenue. However, looking ahead, growing competition in the weight loss market particularly through affordable generics could create headwinds for Eli Lilly and Company (NYSE:LLY). Cramer’s a believer, though:

“Lilly is better [COMPARED TO NOVO], and that’s why Lilly’s stock is up, you know at one point Lilly’s stock was up by 80. That seemed to be aggressive, but Lilly’s got the better data and so therefore this is one of those where whoever loses the most wins. And Lilly’s going to win.

“Now I can’t wait to speak to David Ricks at the JPMorgan healthcare conference, in a couple of weeks because what you’re gonna find is they have so much in the pipe, so many different kinds. People continue to underestimate what Mr. Ricks is working on at Eli Lilly. You know Carl these drugs are going to be very very big again as we get toward a pill, and as we get toward ones that don’t kill, that don’t take a lot of protein away. It’ll be hard pressed for Bobby Kennedy Jr. to say that diet and exercise are enough.

“I mean Novo was this, this was a lot more than we thought that you know what they have it and they can equal or, or exceed Lilly. And they can’t. Lilly up 44. I go back to what the great Ken Langone told me, he thinks it’s a billion dollar company. You know Ken’s one of the great healthcare investors of our time. Trillion dollar company, sorry, and if you believe like I do that Ken Langone is an amazing investor then you still buy Eli Lilly which is why we bought it when it was much lower for the charitable trust.”

Overall LLY ranks 2nd on our list of the stocks Jim Cramer recently talked about. While we acknowledge the potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than LLY but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!